Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis

Bone atrophy and its related fragility fractures are frequent, late side effects of radiotherapy in cancer survivors and have a detrimental impact on their quality of life. In another study, we showed that parathyroid hormone 1-34 and anti-sclerostin antibody attenuates radiation-induced bone damage...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:FASEB J
Asıl Yazarlar: Chandra, Abhishek, Wang, Luqiang, Young, Tiffany, Zhong, Leilei, Tseng, Wei-Ju, Levine, Michael A., Cengel, Keith, Liu, X. Sherry, Zhang, Yejia, Pignolo, Robert J., Qin, Ling
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Federation of American Societies for Experimental Biology 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731129/
https://ncbi.nlm.nih.gov/pubmed/28860152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201700375R
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller